関連する実験動画
Updated: May 6, 2026

07:54
A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice
Published on: July 25, 2017
13.6K
唾液の代謝産物組成,pH,および授乳母豚の胃潰瘍との関連に関する研究
L C Salazar1, E M Baxter1, A B Lawrence2
1Scotland's Rural College, Veterinary and Animal Sciences, West Mains Road, Edinburgh EH9 3JG Scotland, UK.
Animal : an international journal of animal bioscience
|February 19, 2026
まとめ
唾液分析は,豚の胃潰瘍を検出する可能性があることを示しており,これは痛みを引き起こす一般的な問題です. pHではなく,特定の唾液代謝物は,この隠された福祉の懸念の早期バイオマーカーとして機能する可能性があります.
科学分野:
- 獣医医学 獣医医学は,獣医医学というものです.
- 動物科学 動物科学
- バイオケミストリー バイオケミストリー
背景:
- 胃潰瘍は豚に多く見られ,痛みや経済的損失を引き起こす.
- 胃潰瘍の現在の診断方法は侵入的であり,生きた動物での使用を制限しています.
- 豚の胃潰瘍を理解し,管理するために,非侵襲的な診断が必要です.
研究 の 目的:
- 生きた豚の胃潰瘍を検出するための非侵襲的ツールとして唾液代謝産物組成とpHを調査する.
- 子母における胃潰瘍の診断のために唾液分析を使用する可能性を評価する.
主な方法:
- 唾液のサンプルが安楽死前に26頭の母から採取されました.
- 全球代謝と経路濃縮の分析は唾液で行われました.
- 唾液のpH値が測定され,死後の胃の整合性は,スコアリングシステムを使用して評価されました.
主要な成果:
- 豚の69.2%に胃潰瘍があり,中度から重度の食道損傷があった.
- 唾液のpHは胃の整体性と相関していなかった.
- メタボロミック分析では,L-ヒスティジンとリポキシンA4.4を含む食道整体性の変化に関連する特定の唾液代謝物質が特定されました.
結論:
- 唾液代謝産物は,ブタにおける胃潰瘍の潜在的非侵襲的バイオマーカーとして有望であることが示されています.
- 唾液のpHは,この集団における胃潰瘍の信頼できる指標ではありません.
- 胃潰瘍は,豚産業における重要な,潜在的に"隠された"福祉問題です.
関連する概念動画
What is Monogastric Digestion?
56.6K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
56.6K
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
1.6K
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.6K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.6K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.6K
Peptic Ulcer Disease II: Pathophysiology
3.0K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
3.0K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
1.0K
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
1.0K
Serum Laboratory Studies, Stool Test, Breath Test
1.2K
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
1.2K

